125 related articles for article (PubMed ID: 38303264)
1. [Treatment Experience of Chemotherapy and Carbon-Ion Radiotherapy followed by Curative Conversion Surgery for Initially Locally Advanced Unresectable Pancreatic Cancer after Distal Gastrectomy].
Watanabe H; Sugawara S; Takahashi R; Ashitomi Y; Kawashiro S; Sato H; Nemoto K; Kono M; Futakuchi M; Motoi F
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1959-1961. PubMed ID: 38303264
[TBL] [Abstract][Full Text] [Related]
2. Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case report.
Watanabe Y; Tatsuguchi T; Date K; Shinkawa T; Kuga H; Tamiya S; Nishihara K; Nakano T
J Med Case Rep; 2024 Jan; 18(1):13. PubMed ID: 38200536
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Initially Locally Advanced Pancreatic Cancer Curatively Resected after Carbon-Ion Radiotherapy with Gemcitabine].
Miyazaki K; Hayashi H; Ishida M; Ohtsuka H; Mizuma M; Nakagawa K; Morikawa T; Motoi F; Kamei T; Shinoto M; Yamada S; Takiyama H; Unno M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2266-2268. PubMed ID: 33468929
[TBL] [Abstract][Full Text] [Related]
4. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
[TBL] [Abstract][Full Text] [Related]
5. [Multidisciplinary Therapy with Gemcitabine and Nab-Paclitaxel for Unresectable Pancreatic Cancer].
Motoi F; Takadate T; Maeda S; Ariake K; Masuda K; Ishida M; Fukase K; Mizuma M; Ohtsuka H; Sakata N; Hayashi H; Nakagawa K; Morikawa T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1241-1244. PubMed ID: 29394594
[TBL] [Abstract][Full Text] [Related]
6. Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report.
Fujishiro T; Mashiko T; Masuoka Y; Yamada M; Furukawa D; Yazawa N; Kawashima Y; Ogawa M; Hirabayashi K; Nakagohri T
Surg Case Rep; 2018 Sep; 4(1):112. PubMed ID: 30203372
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.
Ariake K; Motoi F; Mizuma M; Murakami K; Takadate T; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Nakagawa K; Sakata N; Morikawa T; Maeda S; Naitoh T; Egawa S; Unno M
Surg Case Rep; 2017 Dec; 3(1):15. PubMed ID: 28101795
[TBL] [Abstract][Full Text] [Related]
8. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
9. [Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report].
Nakamoto S; Nishiyama R; Kaneda T; Yokota M; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Yamauchi H; Okuwaki K; Iwai T; Imaizumi H; Suzuki E; Hara A; Ichinoe M; Kida M; Watanabe M
Gan To Kagaku Ryoho; 2017 Feb; 44(2):173-176. PubMed ID: 28223678
[TBL] [Abstract][Full Text] [Related]
10. Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy.
Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada Y; Kumamoto T; Endo I
World J Surg; 2020 Aug; 44(8):2752-2760. PubMed ID: 32291503
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer.
Shibata Y; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2022 Jun; 15(3):635-641. PubMed ID: 35352239
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study.
Ushida Y; Inoue Y; Oba A; Mie T; Ito H; Ono Y; Sato T; Ozaka M; Sasaki T; Saiura A; Sasahira N; Takahashi Y
Ann Surg Oncol; 2022 Aug; 29(8):5038-5050. PubMed ID: 35294658
[TBL] [Abstract][Full Text] [Related]
13. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
Amano R; Kimura K; Nakata B; Yamazoe S; Motomura H; Yamamoto A; Tanaka S; Hirakawa K
Surgery; 2015 Jul; 158(1):191-200. PubMed ID: 25900035
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Yamada S; Fujii T; Yokoyama Y; Kawashima H; Maeda O; Suzuki K; Okada T; Ono E; Yamaguchi J; Takano N; Takami H; Hayashi M; Niwa Y; Hirooka Y; Ito Y; Naganawa S; Ando Y; Nagino M; Goto H; Kodera Y
Cancer Chemother Pharmacol; 2018 May; 81(5):815-821. PubMed ID: 29502139
[TBL] [Abstract][Full Text] [Related]
15. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Unresectable Locally Advanced Pancreatic Cancer Resulted in R0 Surgery after Chemotherapy].
Sasaki Y; Katayama H; Hosoda Y; Komoto I; Sugimoto T; Yanagihara K; Katsushima U; Kawai J; Kiyochi H; Nishiyama K; Okabe A; Oshima Y; Tsunekawa S; Ogura N; Taki Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1859-1861. PubMed ID: 29394800
[TBL] [Abstract][Full Text] [Related]
17. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
[TBL] [Abstract][Full Text] [Related]
18. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
19. Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial).
Shimomura O; Endo M; Makishima H; Yamada T; Hashimoto S; Numajiri H; Miyazaki Y; Doi M; Furuya K; Takahashi K; Moriwaki T; Hasegawa N; Yamamoto Y; Niisato Y; Kobayashi M; Mizumoto M; Nakai K; Saito T; Hoshiai S; Saida T; Mathis BJ; Mori K; Nakajima T; Tsuchiya K; Sakurai H; Oda T
BMC Cancer; 2023 Jul; 23(1):624. PubMed ID: 37403011
[TBL] [Abstract][Full Text] [Related]
20. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
